Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
357.65
0.00 (0.00%)
Feb 3, 2025, 4:00 PM EST - Market closed
Bio-Rad Laboratories Market Cap
Bio-Rad Laboratories has a market cap or net worth of $9.75 billion as of February 5, 2025. Its market cap has increased by 10.40% in one year.
Market Cap
9.75B
Enterprise Value
9.51B
1-Year Change
10.40%
Ranking
Category
Stock Price
$357.65
Market Cap Chart
Since February 5, 2020, Bio-Rad Laboratories's market cap has decreased from $11.09B to $9.75B, a decrease of -12.08%. That is a compound annual growth rate of -2.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2025 | 9.67B | 5.33% |
| Dec 31, 2024 | 9.18B | -1.24% |
| Dec 29, 2023 | 9.30B | -25.52% |
| Dec 30, 2022 | 12.48B | -44.81% |
| Dec 31, 2021 | 22.62B | 30.09% |
| Dec 31, 2020 | 17.39B | 56.83% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 730.32B |
| UnitedHealth Group | 499.25B |
| Novo Nordisk | 375.61B |
| Johnson & Johnson | 366.32B |
| AbbVie | 324.98B |
| Merck & Co. | 249.98B |
| Thermo Fisher Scientific | 228.64B |
| Abbott Laboratories | 221.89B |